Table 2.
Parameters (mean ± SD) | BS group (n = 5) | B group (n = 6) | S group (n = 5) | C group (n = 6) | χ2 | p |
---|---|---|---|---|---|---|
Dt(×10-3 mm2/s) | 0.599 ± 0.116 | 0.530 ± 0.067 | 0.519 ± 0.068 | 0.475 ± 0.034 | 5.739 | 0.125 |
Dp(×10-3 mm2/s) | 6.114 ± 3.782 | 9.071 ± 5.513 | 11.848 ± 5.092 | 13.988 ± 5.174 | 6.580 | 0.087 |
f | 0.016 ± 0.009 | 0.018 ± 0.009 | 0.024 ± 0.017 | 0.038 ± 0.010 | 8.910 | 0.031 |
MD(×10-3 mm2/s) | 0.695 ± 0.173 | 0.596 ± 0.094 | 0.534 ± 0.103 | 0.505 ± 0.038 | 9.502 | 0.023 |
MK | 0.665 ± 0.132 | 0.903 ± 0.155 | 1.016 ± 0.191 | 1.020 ± 0.123 | 10.375 | 0.016 |
DDC(×10-3 mm2/s) | 0.524 ± 0.079 | 0.459 ± 0.047 | 0.456 ± 0.067 | 0.420 ± 0.018 | 7.523 | 0.057 |
α | 0.912 ± 0.023 | 0.887 ± 0.028 | 0.865 ± 0.046 | 0.853 ± 0.023 | 9.002 | 0.029 |
D(×10-3 mm2/s) | 0.432 ± 0.043 | 0.399 ± 0.024 | 0.398 ± 0.047 | 0.390 ± 0.042 | 3.169 | 0.366 |
β | 0.932 ± 0.026 | 0.906 ± 0.022 | 0.884 ± 0.036 | 0.871 ± 0.039 | 9.739 | 0.021 |
µ(μm) | 5.962 ± 1.130 | 5.745 ± 0.766 | 5.766 ± 1.035 | 4.297 ± 1.540 | 6.795 | 0.079 |
Significant results reported in bold characters. Data are expressed as mean ± SD. B Bufalin treatment, BS Bufalin plus sorafenib treatment, C Control, DDC Distributed diffusion coefficient, MD Mean diffusivity, MK Mean kurtosis, S Sorafenib treatment, SD Standard deviation